[1]张文静,李萍,王燕,等.紫草治疗银屑病临床和实验研究进展[J].中国中医药信息杂志,2020,27(8):141-144,封三.[doi:10.3969/j.issn.1005-5304.201910106]
 ZHANG Wenjing,LI Ping,WANG Yan,et al.Clinical and Experimental Research Progress in Treatment of Psoriasis by Arnebiae Radix[J].zhongguo zhongyiyao xinxi zazhi,2020,27(8):141-144,封三.[doi:10.3969/j.issn.1005-5304.201910106]
点击复制

紫草治疗银屑病临床和实验研究进展

参考文献/References:

[1] 国家药典委员会.中华人民共和国药典:一部[M].北京:中国医药科技出版社,2015:340.

[2] 詹志来,胡峻,刘谈,等.紫草化学成分与药理活性研究进展[J].中国中药杂志,2015,40(21):4127-4135.

[3] 尚俊良,徐佳,王莒生,等.银屑病中医研究概述[J].中医杂志,2017, 58(22):1971-1974.

[4] 甘海芳,蔡东华.银屑病病因病机研究概述[J].中国中西医结合皮肤性病学杂志,2010,9(4):251-253.

[5] 张金超,陈朝霞,李萍,等.银屑病“燥湿互化”的病机理论与“血分辨证”的关系[J].时珍国医国药,2018,29(7):1682-1684.

[6] 姜春燕,邓丙戌,陈凯,等.“从血论治”话“白疕”——谈赵炳南、朱仁康、金起凤三位医家从血论治寻常型银屑病[C]//北京中医药学会,中华中医药学会.北京中医药学会年会论文集:2007年.北京,2008.

[7] 李林,李博鉴.朱仁康老中医治疗银屑病的经验[J].中医杂志,1985, 26(1):12-14.

[8] MENG S, LIN Z, WANG Y, et al. Psoriasis therapy by Chinese medicine and modern agents[J]. Chinese Medicine,2018,13(1):16.

[9] OWCZARCZYK-SACZONEK A, CZERWI?/span>SKA J, PLACEK W. The role of regulatory T cells and anti-inflammatory cytokines in psoriasis[J]. Acta DermatovenerologicaAlpina, Pannonica et Adriatica,2018,27(1):17-23.

[10] KICHINA J V, GOC A, AL-HUSEIN B, et al. PAK1 as a therapeutic target[J]. Expert Opinion on Pharmacotherapy,2010,14(7):703-725.

[11] GALLUZZO M, D’ADAMIO S, SERVOL S, et al. Tofacitinib for the treatment of psoriasis[J]. Expert Opinion on Pharmacotherapy, 2016,17(10):1421-1433.

[12] LU L, QIN A, HUANG H, et al. Shikonin extracted from medicinal Chinese herbs exerts anti-inflammatory effect via proteasome inhibition[J]. Eur J Pharmacol,2011,658(2/3):242-247.

[13] XU Y, XU X, GAO X, et al. Shikonin suppresses IL-17-induced VEGF expression via blockage of JAK2/STAT3 pathway[J]. International Immunopharmacology,2014,19(2):327-333.

[14] 王景山,金学洙,孙国范.紫草注射液治疗银屑病的疗效观察[J].中华皮肤科杂志,1981,14(1):40.

[15] 孙少馨,瞿幸,李玲玲,等.紫草油走罐治疗斑块型银屑病临床研究[J].现代中医临床,2016,23(1):29-32.

[16] 杨艳平.基于数据挖掘的治疗银屑病处方用药规律研究[J].世界中医药,2015,10(10):1611-1613,1617.

[17] TAN Y Q, LIU J L, BAI Y P, et al. Literature research of Chinese medicine recipes for the treatment of psoriasis vulgaris with blood-heat syndrome type[J]. Chinese Journal of Integrative Medicine,2011,17(2):150-153.

[18] 赵帅东.基于数据挖掘技术探讨刘爱民教授治疗寻常型银屑病的用药经验[D].郑州:河南中医药大学,2018.

[19] 王莒生,王萍,邓丙戌,等.张志礼治疗银屑病的用药特点及常用对药配伍[J].中华中医药杂志,2006,21(10):600-601.

[20] 张明,陆捷洁,吴伟伟,等.基于不同剂量的紫草合剂治疗寻常型银屑病的临床观察[J].中国中西医结合皮肤性病学杂志,2018,17(2):149-151.

[21] 景慧玲,吴卫平,卢晓,等.紫草汤治疗寻常型银屑病42例疗效观察[J].河北中医,2015,37(2):188-189.

[22] 胡新平.紫草汤治疗寻常型银屑病36例效果观察[J].世界最新医学信息文摘,2017,17(36):160-163.

[23] 孙丽蕴,陈凯,邓丙戌,等.凉血活血胶囊治疗血热型银屑病的临床研究[J].中国中西医结合皮肤性病学杂志,2002,1(1):16-18.

[24] 曾祖平,石佳,王子君,等.紫草乳膏提取工艺研究[J].世界中医药, 2018,13(11):2872-2875.

[25] 李萍,曾祖平,赵京霞,等.一种治疗银屑病的中药外用乳膏及其制备方法:201510255864.2[P].2015-07-29.

[26] 苏婕.紫草乳膏外用治疗寻常型银屑病血燥证的临床及实验研究[D].北京:北京中医药大学,2016.

[27] 陈玲娜,雷啟容.紫草祛银洗方治疗寻常型银屑病(血热证)的临床观察及护理经验[J].药物生物技术,2018,25(4):326-329.

[28] 刘梅青.紫草提取物对鼠尾角化异常的恢复作用[J].临床皮肤科杂志,2003,32(8):449-450.

[29] 刘梅青.不同剂量紫草醇提取物对鼠尾角化异常的恢复作用[J].岭南皮肤性病科杂志,2003,10(3):145-147.

[30] 刘梅青.不同剂量紫草醇提取物对表皮细胞过度增殖的实验研究[J].临床医药实践,2003,12(7):485-487.

[31] 刘梅青.不同剂量紫草水提液对实验性鼠阴道上皮细胞过度增殖抑制作用的初步研究[J].临床皮肤科杂志,2003,32(12):714-715.

[32] 张文静,付京,张璐,等.紫草标准汤剂成分分析及其抗银屑病作用研究[J].国际中医中药杂志,2019,41(3):273-278.

[33] ZHANG X L, LI J P, YU Y J, et al. Shikonin controls the differentiation of CD4+CD25+ regulatory T cells by inhibiting AKT/ mTOR pathway[J]. Inflammation,2019,42(4):1215–1227.

[34] 行敏,任宏伟,屈慧明,等.寻常型银屑病患者血清中IL-17的表达及紫草素对IL-17刺激HaCaT细胞分泌IL-6和IL-23的影响[J].吉林大学学报(医学版),2017,43(5):958-962.

[35] LIU L L, WU Y, CAO K, et al. Shikonin inhibits IFN-γ induced K17 over-expression of HaCaT cells by interfering with STAT3 signaling[J]. Int J Clin Exp Pathol,2015,8(8):9202–9207.

[36] 解欣然,张蕾,刘欣,等.紫草素对IL-17诱导角质形成细胞增殖及趋化因子表达的影响[J].中国中药杂志,2015,40(5):946-949.

[37] 王燕,赵京霞,林燕,等.紫草素对人外周血单核细胞来源的树突状细胞表型及功能的影响[J].免疫学杂志,2014,30(8):667-670,676.

[38] 吴晓霞,周武庆.紫草素对角质形成细胞株增殖的抑制及凋亡的作用[J].中国麻风皮肤病杂志,2003,19(6):563-566.

[39] YU Y J, XU Y Y, LAN X O, et al. Shikonin induces apoptosis and suppresses growth in keratinocytes via CEBP-δ upregulation[J]. International Immunopharmacology,2019,72:511-521.

[40] 沙先谊,李雅娟,方晓玲.软紫草总酚酸及其在制药中的用途:CN101658542A[P].2010-03-03.

[41] 朱艳红,邓远辉,王海兰.紫草多糖提取工艺参数优选及其分子量测定[J].中国实验方剂学杂志,2010,16(1):6-8.

[42] 王欣,唐志书,杨楠,等.软紫草中抑制PTP1B 活性成分的研究[J].中国药学杂志,2016,51(13):1120-1123.

[43] 毛艳,张瑞萍,贺金华,等.高效液相色谱-四极杆/静电场轨道阱高分辨质谱分析紫草中酚酸类化合物[J].药物分析杂志,2016,36(7):1199- 1206.

[44] 李雅娟,王隽妮,沙先谊,等.新疆紫草抗HIV 有效成分咖啡酸四聚体的理化性质和纯化工艺研究[J].中国中药杂志,2008,33(13):1552- 1555.

[45] KIMG D, PARKY S, JINY H, et al. Production and applications of rosmarinic acid and structurally related compounds[J]. Applied Microbiology and Biotechnology,2015,99(5):2083-2092.

[46] 朱沛沛,李涛涛,赵伟龙,等.紫草多糖的提取、纯化及药理作用研究进展[J].杭州化工,2014,44(1):9-12,26.

[47] SURINA B, MU D, LI W X, et al. Characterizations and immunostimulatory activities of a polysaccharide from Arnebia euchroma (Royle) Johnst. roots[J]. International Journal of Biological Macromolecules,2019,125(15):791-799.

[48] OU Y Y, JIANG Y, LI H, et al. Polysaccharides from Arnebia euchroma ameliorated endotoxic fever and acute lung injury in rats through inhibiting complement system[J]. Inflammation, 2017, 40(1):275-284.

[49] 米克热帕?阿布都买买提,买尔旦?马合木提,古丽仙?胡加.新疆紫草水提部位对小鼠T淋巴细胞亚群和血液学指标的影响[J].海峡药学, 2012,24(2):26-28.

[50] 李啸红,杨柳,姬可平,等.中药紫草的遗传毒性实验研究[J].中国生育健康杂志,2003,14(3):167-169.

[51] 曹璐婷.新疆紫草萘醌类成分的测定及毒性研究[D].长沙:湖南中医药大学,2015.

[52] 赵莎.紫草素对银屑病样模型的干预作用[D].扬州:扬州大学,2016.

[53] RU J L, LI P, WANG J N, et al. TCMSP:a database of systems pharmacology for drug discovery from herbal medicines[J]. Journal of Cheminformatics,2014,6(1):1-6.

相似文献/References:

[1]钱方,杨玉峰,郭岱炯.通导散对银屑病患者微循环的影响[J].中国中医药信息杂志,2010,17(1):17.
 QIAN Fang,YANG Yu-feng,GUO Dai-jiong.Effect of Tongdaosan on Microcirculation in Psoriasis Patients[J].zhongguo zhongyiyao xinxi zazhi,2010,17(8):17.
[2]刘太华,刘德芳,王骏,等.苦参碱、氧化苦参碱、槐定碱对巨噬细胞活性及分泌肿瘤坏死因子-α的影响[J].中国中医药信息杂志,2010,17(3):31.
 LIU Tai-hua,LIU De-fang,WANG Jun,et al.Effects of Matrine, Oxymatrine and Sophordine on Activity and TNF-α Secretion of Macrophage RAW264.7[J].zhongguo zhongyiyao xinxi zazhi,2010,17(8):31.
[3]李伟凡,王萍,王禾.中医辨证治疗泛发性脓疱型银屑病55例临床分析[J].中国中医药信息杂志,2009,16(8):69.
 [J].zhongguo zhongyiyao xinxi zazhi,2009,16(8):69.
[4]欧阳恒.六味地黄丸在皮科临床上的应用[J].中国中医药信息杂志,2008,15(1):82.
 [J].zhongguo zhongyiyao xinxi zazhi,2008,15(8):82.
[5]黄青,瞿幸,吴清.黄连、土大黄、苍术提取液抗银屑病实验研究?[J].中国中医药信息杂志,2008,15(6):30.
 HUANG Qing,QU Xing,WU Qing.Experimental Study of Three Kinds of Chinese Herbs in Treating Psoriasis[J].zhongguo zhongyiyao xinxi zazhi,2008,15(8):30.
[6]张志明.清热消银汤加减治疗银屑病120例疗效观察[J].中国中医药信息杂志,2008,15(8):77.
 [J].zhongguo zhongyiyao xinxi zazhi,2008,15(8):77.
[7]刘靖,储开宇,查旭山.银屑Ⅰ号对银屑病样动物模型的影响[J].中国中医药信息杂志,2011,18(6):43.[doi:10.3969/j.issn.1005-5304.2011.06.018]
 LIU Jing,CHU Kai-yu,ZHA Xu-shan.Effect of Chinese Medicine Psoriasis Prescription Ⅰ on Psoriasis Animal Model[J].zhongguo zhongyiyao xinxi zazhi,2011,18(8):43.[doi:10.3969/j.issn.1005-5304.2011.06.018]
[8]吐尔洪·艾买尔,居来提·托合提,斯拉甫·艾白,等.维吾尔医诊断银屑病回顾性调查分析[J].中国中医药信息杂志,2011,18(10):24.[doi:10.3969/j.issn.1005-5304.2011.10.009]
 Turgun Amar,Jurat Tohti,Sirap Abai,et al.Retrospective Survey and Analysis on Psoriasis Diagnosed in Uyghur Medicine[J].zhongguo zhongyiyao xinxi zazhi,2011,18(8):24.[doi:10.3969/j.issn.1005-5304.2011.10.009]
[9]居来提·托合提,吐尔洪·艾买尔,斯拉甫·艾白,等.维吾尔医治疗银屑病回顾性调查分析[J].中国中医药信息杂志,2011,18(11):20.[doi:10.3969/j.issn.1005-5304.2011.11.008]
 Jurat Tohti,Turgun Amar,Sirap Abai,et al.Retrospective Survey and Analysis on Psoriasis Treated by Uyghur Medicine[J].zhongguo zhongyiyao xinxi zazhi,2011,18(8):20.[doi:10.3969/j.issn.1005-5304.2011.11.008]
[10]姜春燕,谭勇,杨静,等.利用文本挖掘技术分析银屑病中医用药规律[J].中国中医药信息杂志,2011,18(11):28.[doi:10.3969/j.issn.1005-5304.2011.11.011]
 JIANG Chun-yan,TAN Yong,YANG Jing,et al.Analysis on Regularity of Chinese Herbs Application for Psoriasis with Text Mining Technique[J].zhongguo zhongyiyao xinxi zazhi,2011,18(8):28.[doi:10.3969/j.issn.1005-5304.2011.11.011]

备注/Memo

基金项目:北京市自然科学基金重点项目(7171003)

更新日期/Last Update:

2020-07-20